Allison Jeynes-EllisChief Executive Officer at Avillion LLP
Allison has more than 25 years’ experience in the life sciences industry, predominantly within research and development. A physician by background, a recognised oncology specialist, with broad experience across other therapy areas, she has held a range of senior roles, including Medical Director for Wyeth for 6 years and International Project Team Leader for many compounds in development, leading global Phase III programmes through to successful US and EU filings.
Allison worked as an independent consultant for many years with clients including: Genentech, J&J, Takeda Europe, Novartis, Roche, AZ, Sanofi, Lundbeck and Ipsen to name a few. She started as CMO for Avillion LLP leading the due diligence activities around the first deal Avillion delivered on for Pfizer and then stepped up to become CEO nearly five years ago.
Allison also sits on the Board of Directors of Agenus and Anaveon.